Cargando…
Treatment for emerging viruses: Convalescent plasma and COVID-19
Use of convalescent plasma transfusions could be of great value in the current pandemic of coronavirus disease (COVID-19), given the lack of specific preventative and therapeutic options. This convalescent plasma therapy is of particular interest when a vaccine or specific therapy is not yet availab...
Autores principales: | Brown, Bethany L., McCullough, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194745/ https://www.ncbi.nlm.nih.gov/pubmed/32345485 http://dx.doi.org/10.1016/j.transci.2020.102790 |
Ejemplares similares
-
Response Letter: Treatment for emerging viruses: Convalescent plasma and COVID-19
por: Brown, Bethany
Publicado: (2021) -
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19
por: Psaltopoulou, Theodora, et al.
Publicado: (2020) -
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021) -
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
por: Beraud, Mickael, et al.
Publicado: (2022) -
Use of convalescent plasma in COVID‐19 patients with immunosuppression
por: Senefeld, Jonathon W., et al.
Publicado: (2021)